Trial intelligence / Profile preview

Influvac in adults with hypo- or dysgammaglobulinemia

NL-OMON23525Active, not recruiting

Start
Oct 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of influenza vaccine in influenza (3 arms), sponsored by None. Primary endpoint: Cellular immune responses. Started Oct 2006; status: active, not recruiting.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON23525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call